Clinical TB: A Focused Clinical & Public Health Review for Healthcare Workers
McGill University | June 17-19, 2019 | Montreal, Quebec
APPLY TODAY
2019 final agenda
Course Description:
This 3 day course provides a concise review of the clinical and public health aspects of managing TB. It will be of particular interest to healthcare workers and trainees in Canada, or other low TB incidence countries, who are seeking to develop or strengthen their TB management skills. Topics will include TB epidemiology in Canada, latent TB infection (LTBI), the medical evaluation of potentially active TB, diagnosis and management of active TB, TB in children, contact tracing, and outbreak management. Emerging topics and controversies in TB diagnosis and treatment will also be discussed. The course format will be a combination of lectures and interactive case presentations. The course faculty are nurses, public health professionals, and clinicians with expertise in TB management within the Canadian context.
Course Directors:
Faiz Ahmad Khan, MD FRCPC MPH
Assistant Professor, Division of Respiratory Medicine, McGill University;
Medical Director, Montreal Chest Institute TB Clinic, McGill University Health Centre;
Associate Director, McGill International TB Centre
James Johnston, MD FRCPC MPH
Clinical Associate Professor
Division of Respiratory Medicine, University of British Columbia.
TB Services, BC Centre for Disease Control
Course Faculty:
Marcel Behr, MD, MSc – McGill University
Sarah Brode, MD, FRCPC, MPH – University of Toronto & TB Program, West Park Healthcare Centre
Latoya Campbell, MDCM – Ungava Tulattavik Health Center, Kuujjuaq & Kangiqsuluajjuaq
Ryan Cooper, MD, FRCP, MPH – University of Alberta & Provincial TB Program, Alberta Health Services
Claire Crépeau, Inf. BScN – Nunavik Regional Board of Health and Social Services
Amrita Daftary, PhD, MPH – McGill University
Denis Francis, B.Sc. Inf. – Montreal Chest Institute
Cheryl Giffin, BScN – BC Centre for Disease Control
Jessika Huard, Inf. M.Sc.- CIUSSS du Centre-Sud-de-l’Île-de-Montréal
Richard Long, MD, FRCPC, FCCP – University of Alberta, TB Program Evaluation & Research Unit
Dick Menzies, MD, MSc – McGill University
Lavanya Narasiah, MD, MSc, CCFP – Clinique des Réfugiés CSSS Champlain & McGill University
Elizabeth Rea, MD, MSc, FRCPC – Toronto Public Health & University of Toronto
Marie Rochette, MSc, FRCPC – Director of Public Health, Nunavik Regional Board of Health and Social Services
Noémie Savard, MD MSc FRCPC - Direction régionale de santé publique du CIUSSS du Centre-Sud-de-l'Île-de-Montréal
Hilda Snowball – Vice Chair Person, Kativik Regional Government
Amélie Tchabo Fosso, B.Sc. Inf. – Montreal Chest Institute
David Zielinski MD, FRCPC, FCCP – McGill University
Content
In Canada and other low tuberculosis (TB) incidence countries, many healthcare professionals complete their training with limited experience in the management of TB infection, disease, and outbreaks. However, certain populations in these countries have an elevated risk of TB, including some Indigenous communities, migrants, and marginalized groups. It is key for clinicians and public health professionals that work with these populations to have strong TB management skills. This course will provide an intensive review of the clinical and public health aspects of managing TB, with a focus on Canada and other low-incidence countries. By the end of the course, participants will be able to identify populations at higher risk of TB infection and disease in Canada, diagnose and treat latent TB infection (LTBI), identify and medically evaluate persons with possible active TB, treat active TB, and understand the fundamentals of contact tracing and management.
Participants will also strengthen their understanding on the management of TB in special populations and settings, including Indigenous communities and outbreak settings. In addition, emerging topics and controversies in TB and LTBI management will be discussed, such as use of PCR-based diagnostics, whole genome sequencing, interferon gamma release assays, and new drug regimens for TB prevention and treatment. The course format will be a combination of lectures and interactive case presentations.
Learning Objectives
Course participants will:
- Learn to manage LTBI in adults and children, including indications for testing, diagnosis, treatment, and monitoring.
- Learn the approach to evaluate people with possible active TB.
- Learn how to manage active TB in adults and children, including diagnosis, treatment, and monitoring.
- Learn about emerging technologies in diagnosis, treatment and prevention of TB.
- Understand the basics of diagnosis and treatment of drug-resistant TB infection and disease.
- Develop an approach to contact tracing and management.
- Understand issues specific to clinical and public health aspects in special populations.
- Review legal aspects of TB control
- Understand infection control principles in healthcare settings
- Expected practice outcomes:
- Improved skills in screening, diagnosis, treatment of active TB in adults and children
- Improved skills in TST planting, reading, interpretation
- Improved skills in contact tracing
Target Audience
Healthcare professionals or trainees (nurses, physicians, public health professionals) involved in screening, diagnosis, or treatment.
Enrolment
Maximum of 40 participants
Application Instructions
Click here for application form
Deadlines:
Deadline extended to May 10th
*Payment information will be provided upon confirmation and acceptance of your application.
*Please do not make any travel arrangements until your application has been accepted.
Category:
- Students and trainees from McGill University and its affiliated hospitals $350 CAD
- Applicants working or studying in low or middle income countries $600 CAD
- Other students and trainees from high-income countries who are registered at a college of university and Registered nurses $750 CAD
- Industry applicants $2,150 CAD
- All other applicants $985 CAD
Taxes may apply
* Fees include course materials and instructions as well as lunch on the days courses are given and a social mixer each week. Other fees (travel, accommodation, visa, etc.) are the responsibility of the participant.
Directors of the course on Clinical TB
Faiz Ahmad Khan, MD, FRCPC, MPH
Dr. Faiz Ahmad Khan is an Assistant Professor in the Faculty of Medicine at McGill University, an Associate Director of the McGill International TB Centre, and works as a respirologist at the McGill University Health Centre and in Nunavik (the Inuit region in the province of Quebec). He is also the medical director of the TB Clinic at the Montreal Chest Institute. His clinical and research work includes a focus on TB and lung health in Quebec's Indigenous populations. His first foray into lung health research in Nunavik was in 2009, and he has been providing clinical services in the region since 2012. He co-founded the RESP-NORTH remote consultation and triage service with Dick Menzies. Dr. Khan is also co-leading research collaborations on TB and lung health in Karachi, Pakistan, as well as research initiatives evaluating software programs that analyze chest x-rays to detect TB, and collaborative studies assessing the effectiveness of shorter standardized regimens for MDR-TB.
James Johnston, MD, FRCPC, MPH
Dr. James Johnston is a Clinical Associate Professor in the Faculty of Medicine at UBC. He completed Internal Medicine training at McGill before moving to UBC for his Respiratory Medicine Fellowship. He completed postdoctoral TB research training at the BC Centre for Disease Control, and has a Master’s in Public Health from Harvard School of Public Health. His clinical and research interests include tuberculosis in migrants and new technologies to address challenges in TB elimination.
